Celebrex may slow colon cancer

August 31, 2006

Two U.S. studies say Pfizer's painkiller Celebrex can slow the recurrence of polyps in the colon for those at a higher risk of developing colon cancer.

But they also caution about an increased risk of heart attacks and strokes from the medicine, reports the Wall Street Journal.

The findings of the studies are published in this week's edition of the New England Journal of Medicine. Celebrex is commonly taken to relieve arthritis pain.

An editorial in the medical journal said because of the cardiovascular risk, Celebrex, or its generic version, has "no role" in preventing cancer in those who don't face high risk of colon cancer, the report said. Early testing is recommended for discovering polyps so they can be removed.

A Pfizer expert was quoted as saying the cancer results are encouraging but added, "We do not recommend Celebrex in treating and preventing cancer." He said the medicine, however, remains an important treatment option for arthritis sufferers.

Copyright 2006 by United Press International

Explore further: Celebrex inhibited the burden of skin cancer in high-risk patients

Related Stories

When is a drug too risky to stay on the market?

June 30, 2010

(AP) -- The arthritis pill Vioxx was withdrawn but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on. So, when is a drug too risky to ...

Can Celebrex prevent cancer-causing colon polyps?

May 13, 2010

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable ...

Recommended for you

Most EU nations seek to bar GM crops

October 4, 2015

Nineteen of the 28 EU member states have applied to keep genetically modified crops out of all or part of their territory, the bloc's executive arm said Sunday, the deadline for opting out of new European legislation on GM ...

The dark side of Nobel prizewinning research

October 4, 2015

Think of the Nobel prizes and you think of groundbreaking research bettering mankind, but the awards have also honoured some quite unhumanitarian inventions such as chemical weapons, DDT and lobotomies.

Internet giants race to faster mobile news apps

October 4, 2015

US tech giants are turning to the news in their competition for mobile users, developing new, faster ways to deliver content, but the benefits for struggling media outlets remain unclear.

Fusion reactors 'economically viable' say experts

October 2, 2015

Fusion reactors could become an economically viable means of generating electricity within a few decades, and policy makers should start planning to build them as a replacement for conventional nuclear power stations, according ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.